Key result
Lubiprostone reduces iPS-CM spontaneous beating rate by ~29% via CFTR activation.
Why the study?
The effect of lubiprostone on cardiomyocytes has not yet been investigated despite known expression of ClC-2 and CFTR in these cells.
Does lubiprostone reduce the spontaneous beating rate and contraction ratio in mouse cardiomyocytes?
Does lubiprostone reduce the spontaneous beating rate and contraction ratio in mouse cardiomyocytes?
Lubiprostone demonstrates negative chronotropic and inotropic effects on mouse cardiomyocytes via CFTR activation, highlighting a potential novel mechanism for cardiac therapies.
Answers are grounded in this paper and cite their sources.
Lubiprostone effects on cardiomyocytes remain preclinical; leaves open any cardiac therapeutic role pending targeted studies.
BACKGROUND: Lubiprostone (LBP) is a novel chloride channel opener that has been reported to activate chloride channel protein 2 (ClC-2) and cystic fibrosis transmembrane conductance regulator (CFTR). LBP facilitates fluid secretion by activating CFTR in the intestine and is used as a drug for treating chronic constipation. While ClC-2 and CFTR expression has been confirmed in cardiomyocytes (CMs), the effect of LBP on CMs has not yet been investigated. Thus, the present study aimed to investigate the effect of LBP on CMs using mouse-induced pluripotent stem (iPS) cell-derived CMs (iPS-CMs). METHODS: We induced mouse iPS cells into CMs through embryoid body (EB) formation. We compared the differentiated cells to CMs isolated from adult and fetal mice using gene expression, spontaneous beating rate, and contraction ratio analyses. RESULTS: Gene expression analysis revealed that, in the iPS-CMs, the mRNA expression of the undifferentiated cell markers Rex1 and Nanog decreased, whereas the expression of the unique cardiomyocyte markers cardiac troponin I (cTnI) and cardiac troponin T (cTNT), increased. Immunostaining showed that the localization of cTnI and connexin-43 in the iPS-CMs was similar to that in the primary fetal CMs (FCMs) and adult CMs (ACMs). LBP decreased the spontaneous beating rate of the iPS-CMs and FCMs, and decreased the contraction ratio of the iPS-CMs and ACMs. The reduction in the beating rate and contraction ratio caused by LBP was inhibited by glycine hydrazide (GlyH), which is a CFTR inhibitor. CONCLUSION: These results suggest that LBP stimulates CFTR in CMs and that LBP has negative chronotropic and inotropic effects on CMs. LBP may be useful for treating cardiac diseases such as heart failure, ischemia, and arrhythmia.
No takes yet. Share an insight, caveat, or question.
Akita et al. (2020) studied Healthy mice (for isolation of cardiomyocytes) (n=24). Lubiprostone vs. Control / Baseline was evaluated on Spontaneous beating rate (bpm) of iPS-CMs (p=<0.05). Lubiprostone decreased the spontaneous beating rate of iPS-CMs from 48.8 to 34.5 bpm and reduced the contraction ratio via activation of CFTR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: